Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Neumora Therapeutics, Inc. Common Stock (NMRA)
USD1.64
+0.06 (+3.80%)
US NASDAQ Healthcare Biotechnology
Address
490 Arsenal Way 2472
Watertown, DE, US
Watertown, DE, US
CEO
Daljit Singh Aurora
Website
neumoratx.com
IPO
2023-09-15
CIK 1885522 ISIN US6409791000
Description
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.64
+0.06 (+3.80%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
2.76
Float Shares
62.29M
Free Float %
33.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.60% | -3.14% | -25.10% | -46.99% | -17.41% | +3.35% | +147.36% | -88.62% | -88.62% | -88.62% | -88.62% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (9 ratings, all time)
Buy
Price Targets & DCF
Current price
1.64
Low
6.00
+265.9%
Consensus
7.00
+326.8%
Median
7.00
+326.8%
High
8.00
+387.8%
DCF (Unlevered)
1.10
-33.1%
DCF (Levered)
1.11
-32.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
78% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 4 |
7.25
+342.1%
|
| All Time | 12 |
15.67
+855.5%
|
Quality scores
Altman Z-Score
-12.51
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+5.2% Q1'26: +28.6% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +278.3% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+2.5% ★ Q1'26: +11.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 9 Rev. Ana. 8 EPS Ana. |
Dec 2027 6 Rev. Ana. 7 EPS Ana. |
Dec 2028 8 Rev. Ana. 8 EPS Ana. |
Dec 2029 7 Rev. Ana. 6 EPS Ana. |
Dec 2030 7 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
625.0K
625.0K – 625.0K
|
5.89M
5.89M – 5.89M
+842.5% YoY
|
69.61M
69.61M – 69.61M
+1,081.6% YoY
|
206.08M
206.08M – 206.08M
+196.1% YoY
|
434.62M
434.62M – 434.62M
+110.9% YoY
|
| EBITDA |
-262.83M
|
-233.37M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-263.46M
|
-233.58M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-243.79M
est: -245.58M (+0.7%)
|
-236.93M
est: -234.23M (-1.2%)
|
-185.05M
-206.61M – -102.50M
+21.0% YoY
|
-200.44M
-202.41M – -63.15M
-8.3% YoY
|
-109.34M
-187.90M – -30.78M
+45.5% YoY
|
-81.70M
-81.70M – -81.70M
+25.3% YoY
|
18.91M
18.91M – 18.91M
+123.1% YoY
|
| SGA |
62.54M
|
60.09M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1.53
est: -1.58 (+2.9%)
|
-1.45
est: -1.42 (-1.9%)
|
-0.96
-1.26 – -0.63
+32.5% YoY
|
-0.89
-1.24 – -0.39
+7.1% YoY
|
-0.82
-1.15 – -0.19
+8.2% YoY
|
-0.50
-0.50 – -0.50
+38.9% YoY
|
0.12
0.12 – 0.12
+123.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
121
Total invested
137.25M
Insider transactions (90d)
5
Beneficial owners (>5%)
20
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Amgen Inc. | 35.37M | 23.20% | 35.37M | — | 35.37M | — | CO | — | 2023-09-27 | ↗ |
| 2 | Kristina Burow | 29.80M | 19.60% | 16.2K | 29.78M | 16.2K | 29.78M | IN | States | 2023-10-02 | ↗ |
| 3 | ARCH Venture Fund VII, L.P. | 29.78M | 19.60% | — | 29.78M | — | 29.78M | PN | Delaware | 2023-10-02 | ↗ |
| 4 | ARCH Venture Fund VIII Overage, L.P. | 29.78M | 19.60% | — | 29.78M | — | 29.78M | PN | Delaware | 2023-10-02 | ↗ |
| 5 | ARCH Venture Fund X, L.P. | 29.78M | 19.60% | — | 29.78M | — | 29.78M | PN | Delaware | 2023-10-02 | ↗ |
| 6 | ARCH Venture Partners VIII, LLC | 29.78M | 19.60% | — | 29.78M | — | 29.78M | OO | Delaware | 2023-10-02 | ↗ |
| 7 | ARCH Venture Partners XII, L.P. | 29.78M | 19.60% | — | 29.78M | — | 29.78M | PN | Delaware | 2023-10-02 | ↗ |
| 8 | Keith Crandell | 29.78M | 19.60% | — | 29.78M | — | 29.78M | IN | States | 2023-10-02 | ↗ |
| 9 | Robert Nelsen | 29.78M | 19.60% | — | 29.78M | — | 29.78M | IN | States | 2023-10-02 | ↗ |
| 10 | Venture Fund X Overage, L.P. | 29.78M | 19.60% | — | 29.78M | — | 29.78M | PN | Delaware | 2023-10-02 | ↗ |
| 11 | Venture Fund XII, L.P. | 29.78M | 19.60% | — | 29.78M | — | 29.78M | PN | Delaware | 2023-10-02 | ↗ |
| 12 | Venture Partners VII, L.P. | 29.78M | 19.60% | — | 29.78M | — | 29.78M | PN | Delaware | 2023-10-02 | ↗ |
| 13 | Venture Partners X Overage, L.P. | 29.78M | 19.60% | — | 29.78M | — | 29.78M | PN | Delaware | 2023-10-02 | ↗ |
| 14 | Venture Partners X, L.P. | 29.78M | 19.60% | — | 29.78M | — | 29.78M | PN | Delaware | 2023-10-02 | ↗ |
| 15 | Venture Partners XII, LLC | 29.78M | 19.60% | — | 29.78M | — | 29.78M | OO | Delaware | 2023-10-02 | ↗ |
| 16 | Gillis | 28.64M | 18.90% | — | 28.64M | — | 28.64M | IN | States | 2023-10-02 | ↗ |
| 17 | Paul L Berns | 7.98M | 5.20% | 7.98M | — | 7.98M | — | IN | United States of America | 2024-02-14 | ↗ |
| 18 | SVF II Holdings (DE) LLC | 7.65M | 5.00% | — | 7.65M | — | 7.65M | OO | Japan | 2024-02-13 | ↗ |
| 19 | SoftBank Group Corp. | 7.55M | 4.70% | — | 7.55M | — | 7.55M | CO | Japan | 2024-11-12 | ↗ |
| 20 | Bybee | 1.83M | 1.20% | — | 1.83M | — | 1.83M | IN | States | 2023-10-02 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
121
+14 vs prev Q
New positions
24
Closed positions
13
Increased
59
Reduced
31
Put/Call ratio
0.61
Calls held
1.28M
Puts held
781.5K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | SOFTBANK GROUP CORP. | 6.43M -111.5K (-1.7%) | 11.51M -395.8K (-3.3%) | 3.97% -0.073 pp | 0.07% +0.029 pp | USD14.11 -87.3% | 10 qtrs — |
| 2 | SIREN, L.L.C. | 6.29M +1.9M (+44.3%) | 11.26M +3.3M (+41.9%) | 3.89% +1.190 pp | 0.34% +0.026 pp | USD8.97 -80.0% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 4.54M +490.1K (+12.1%) | 8.13M +755.8K (+10.3%) | 2.80% +0.301 pp | 0.00% +0.000 pp | USD8.94 -80.0% | 10 qtrs — |
| 4 | MIC CAPITAL MANAGEMENT UK LLP | 4.46M +— (+0.0%) | 7.98M -133.8K (-1.6%) | 2.76% -0.003 pp | 1.81% +0.187 pp | USD14.11 -87.3% | 10 qtrs — |
| 5 | POINT72 ASSET MANAGEMENT, L.P. | 3.67M +3.7M (+100.0%) | 6.58M +6.6M (+100.0%) | 2.27% +2.270 pp | 0.01% +0.007 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 6 | MILLENNIUM MANAGEMENT LLC | 3.62M +1.6M (+80.1%) | 6.47M +2.8M (+77.1%) | 2.23% +0.993 pp | 0.00% +0.001 pp | USD2.17 -17.5% | 5 qtrs — |
| 7 | FMR LLC | 3.50M -3.5K (-0.1%) | 6.26M -111.3K (-1.7%) | 2.16% -0.004 pp | 0.00% +0.000 pp | USD13.73 -87.0% | 10 qtrs — |
| 8 | WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST | 3.31M +— (+0.0%) | 5.92M -99.3K (-1.6%) | 2.04% -0.002 pp | 0.06% -0.002 pp | USD14.11 -87.3% | 10 qtrs — |
| 9 | ICONIQ CAPITAL, LLC | 2.56M +— (+0.0%) | 4.58M -76.8K (-1.6%) | 1.58% -0.001 pp | 0.07% +0.011 pp | USD17.05 -89.5% | 9 qtrs — |
| 10 | LUNATE CAPITAL LTD | 2.12M +— (+0.0%) | 3.80M -63.7K (-1.6%) | 1.31% -0.001 pp | 1.44% +0.856 pp | USD1.00 +79.0% | 4 qtrs — |
| 11 | BLACKROCK, INC. | 2.02M +209.0K (+11.5%) | 3.62M +319.7K (+9.7%) | 1.25% +0.128 pp | 0.00% +0.000 pp | USD11.73 -84.7% | 6 qtrs — |
| 12 | JOHNSON & JOHNSON | 1.85M +— (+0.0%) | 3.31M -55.5K (-1.6%) | 1.14% -0.001 pp | 0.60% -0.068 pp | USD15.60 -88.5% | 10 qtrs — |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 1.45M +281.9K (+24.2%) | 2.59M +469.7K (+22.2%) | 0.89% +0.174 pp | 0.00% +0.001 pp | USD1.13 +58.4% | 4 qtrs — |
| 14 | TWO SIGMA INVESTMENTS, LP | 1.31M +1.0M (+336.2%) | 2.34M +1.8M (+329.0%) | 0.81% +0.623 pp | 0.00% +0.003 pp | USD1.74 +2.9% | 7 qtrs — |
| 15 | IKARIAN CAPITAL, LLC | 1.28M +1.3M (+10,128.9%) | 2.29M +2.3M (+9,960.0%) | 0.79% +0.782 pp | 0.18% +0.176 pp | USD1.78 +0.6% | 4 qtrs — |
| 16 | JANE STREET GROUP, LLC | 1.13M +973.1K (+624.1%) | 2.02M +1.7M (+612.2%) | 0.70% +0.601 pp | 0.00% +0.000 pp | USD1.84 -2.7% | 9 qtrs — |
| 17 | TWO SIGMA ADVISERS, LP | 1.08M +106.4K (+10.9%) | 1.94M +161.1K (+9.1%) | 0.67% +0.065 pp | 0.00% +0.000 pp | USD0.87 +105.7% | 4 qtrs — |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 1.00M +34.8K (+3.6%) | 1.80M +33.2K (+1.9%) | 0.62% +0.021 pp | 0.00% +0.000 pp | USD11.55 -84.5% | 10 qtrs — |
| 19 | TANG CAPITAL MANAGEMENT LLC | 967.2K -432.8K (-30.9%) | 1.73M -816.6K (-32.1%) | 0.60% -0.268 pp | 0.09% -0.013 pp | USD1.00 +79.0% | 4 qtrs — |
| 20 | GOLDMAN SACHS GROUP INC | 858.5K +481.1K (+127.5%) | 1.54M +849.9K (+123.7%) | 0.53% +0.297 pp | 0.00% +0.000 pp | USD6.31 -71.6% | 10 qtrs — |
| 21 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 738.3K +314.0K (+74.0%) | 1.32M +549.4K (+71.2%) | 0.46% +0.194 pp | 0.00% +0.000 pp | USD1.96 -8.7% | 10 qtrs — |
| 22 | ALPHACORE CAPITAL LLC | 638.8K +— (+0.0%) | 1.14M -19.2K (-1.6%) | 0.39% 0.000 pp | 0.03% -0.014 pp | USD1.25 +43.2% | 3 qtrs — |
| 23 | MARSHALL WACE, LLP | 583.8K +583.8K (+100.0%) | 1.04M +1.0M (+100.0%) | 0.36% +0.361 pp | 0.00% +0.001 pp | USD1.79 +0.0% | 3 qtrs — |
| 24 | GSA CAPITAL PARTNERS LLP | 534.0K +425.6K (+392.6%) | 956.0K +759.0K (+385.3%) | 0.33% +0.263 pp | 0.08% +0.066 pp | USD1.59 +12.6% | 4 qtrs — |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 512.5K -469.0 (-0.1%) | 917.3K -16.2K (-1.7%) | 0.32% -0.001 pp | 0.00% +0.000 pp | USD11.56 -84.5% | 9 qtrs — |
| 26 | CITADEL ADVISORS LLC | 505.8K +505.8K (+100.0%) | 905.4K +905.4K (+100.0%) | 0.31% +0.313 pp | 0.00% +0.000 pp | USD1.79 +0.0% | 10 qtrs — |
| 27 | JACOBS LEVY EQUITY MANAGEMENT, INC | 474.5K -356.3K (-42.9%) | 849.3K -662.8K (-43.8%) | 0.29% -0.221 pp | 0.00% -0.003 pp | USD1.82 -1.6% | 2 qtrs — |
| 28 | STATE STREET CORP | 388.9K +— (+0.0%) | 696.2K -11.7K (-1.6%) | 0.24% 0.000 pp | 0.00% +0.000 pp | USD10.89 -83.6% | 9 qtrs — |
| 29 | BOOTHBAY FUND MANAGEMENT, LLC | 335.3K +335.3K (+100.0%) | 600.1K +600.1K (+100.0%) | 0.21% +0.207 pp | 0.01% +0.009 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 30 | FEDERATED HERMES, INC. | 314.1K +— (+0.0%) | 562.3K -9.4K (-1.6%) | 0.19% 0.000 pp | 0.00% 0.000 pp | USD0.97 +84.5% | 4 qtrs — |
| 31 | CERITY PARTNERS LLC | 275.1K -13.4K (-4.6%) | 492.5K -32.6K (-6.2%) | 0.17% -0.008 pp | 0.00% 0.000 pp | USD10.16 -82.4% | 6 qtrs — |
| 32 | MORGAN STANLEY | 238.5K -36.3K (-13.2%) | 426.9K -73.2K (-14.6%) | 0.15% -0.023 pp | 0.00% +0.000 pp | USD8.74 -79.5% | 10 qtrs — |
| 33 | ACADIAN ASSET MANAGEMENT LLC | 239.3K -33.2K (-12.2%) | 426.0K -65.0K (-13.2%) | 0.15% -0.021 pp | 0.00% 0.000 pp | USD0.74 +141.9% | 6 qtrs — |
| 34 | INVESCO LTD. | 227.6K +43.8K (+23.8%) | 407.4K +72.9K (+21.8%) | 0.14% +0.027 pp | 0.00% +0.000 pp | USD3.37 -46.9% | 7 qtrs — |
| 35 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 225.0K +— (+0.0%) | 402.8K -6.8K (-1.6%) | 0.14% 0.000 pp | 0.01% 0.000 pp | USD1.22 +46.7% | 3 qtrs — |
| 36 | GRAHAM CAPITAL MANAGEMENT, L.P. | 191.4K +34.5K (+22.0%) | 342.6K +57.0K (+20.0%) | 0.12% +0.021 pp | 0.01% +0.004 pp | USD1.59 +12.6% | 5 qtrs — |
| 37 | SQUAREPOINT OPS LLC | 185.8K +173.1K (+1,355.1%) | 332.6K +309.4K (+1,331.1%) | 0.11% +0.107 pp | 0.00% +0.000 pp | USD1.74 +2.9% | 4 qtrs — |
| 38 | NORTHERN TRUST CORP | 185.4K +27.6K (+17.5%) | 331.8K +44.6K (+15.5%) | 0.11% +0.017 pp | 0.00% +0.000 pp | USD11.82 -84.9% | 9 qtrs — |
| 39 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 180.9K +180.9K (+100.0%) | 323.7K +323.7K (+100.0%) | 0.11% +0.112 pp | 0.00% +0.003 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 40 | ADDIS & HILL, INC | 163.4K +— (+0.0%) | 292.5K +1.6K (+0.6%) | 0.10% 0.000 pp | 0.18% 0.000 pp | USD13.94 -87.2% | 8 qtrs — |
| 41 | — | 163.4K +163.4K (+100.0%) | 292.5K +292.5K (+100.0%) | 0.10% +0.101 pp | 0.18% +0.177 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 42 | ENTRYPOINT CAPITAL, LLC | 145.4K +145.4K (+100.0%) | 260.2K +260.2K (+100.0%) | 0.09% +0.090 pp | 0.10% +0.102 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 43 | OMERS ADMINISTRATION CORP | 137.3K +137.3K (+100.0%) | 245.8K +245.8K (+100.0%) | 0.08% +0.085 pp | 0.00% +0.002 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 44 | XTX TOPCO LTD | 113.9K +113.9K (+100.0%) | 203.9K +203.9K (+100.0%) | 0.07% +0.070 pp | 0.01% +0.005 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 45 | DIMENSIONAL FUND ADVISORS LP | 107.3K +2.3K (+2.2%) | 192.0K +909.0 (+0.5%) | 0.07% +0.001 pp | 0.00% +0.000 pp | USD1.02 +75.5% | 4 qtrs — |
| 46 | RBF CAPITAL, LLC | 105.2K -34.8K (-24.9%) | 188.3K -66.5K (-26.1%) | 0.07% -0.022 pp | 0.01% -0.003 pp | USD0.73 +145.2% | 3 qtrs — |
| 47 | BANK OF AMERICA CORP /DE/ | 102.4K -35.0K (-25.5%) | 183.3K -66.8K (-26.7%) | 0.06% -0.022 pp | 0.00% +0.000 pp | USD2.01 -10.9% | 9 qtrs — |
| 48 | SKYOAK WEALTH, LLC | 100.0K +— (+0.0%) | 179.0K -3.0K (-1.6%) | 0.06% 0.000 pp | 0.03% -0.002 pp | USD0.73 +145.2% | 7 qtrs — |
| 49 | VIRTU FINANCIAL LLC | 97.4K +80.2K (+465.7%) | 174.0K +143.0K (+461.3%) | 0.06% +0.050 pp | 0.01% +0.005 pp | USD1.80 -0.6% | 4 qtrs — |
| 50 | UBS GROUP AG | 94.9K -34.1K (-26.5%) | 169.9K -65.0K (-27.7%) | 0.06% -0.021 pp | 0.00% +0.000 pp | USD4.84 -63.0% | 9 qtrs — |
| 51 | AQR CAPITAL MANAGEMENT LLC | 94.2K -113.5K (-54.7%) | 168.6K -209.4K (-55.4%) | 0.06% -0.070 pp | 0.00% 0.000 pp | USD0.89 +101.1% | 4 qtrs — |
| 52 | CANADA PENSION PLAN INVESTMENT BOARD | 91.7K +91.7K (+100.0%) | 164.1K +164.1K (+100.0%) | 0.06% +0.057 pp | 0.00% +0.000 pp | USD1.79 +0.0% | 3 qtrs — |
| 53 | MERIDIAN WEALTH MANAGEMENT, LLC | 86.4K +27.0K (+45.5%) | 154.7K +46.5K (+43.1%) | 0.05% +0.017 pp | 0.01% +0.001 pp | USD1.81 -1.1% | 2 qtrs — |
| 54 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 76.7K +— (+0.0%) | 137.3K -2.3K (-1.6%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD10.60 -83.1% | 5 qtrs — |
| 55 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 72.1K +30.9K (+74.8%) | 129.1K +54.0K (+72.0%) | 0.04% +0.019 pp | 0.00% +0.001 pp | USD1.81 -1.1% | 2 qtrs — |
| 56 | SG AMERICAS SECURITIES, LLC | 66.1K +579.0 (+0.9%) | 118.0K -1.0K (-0.8%) | 0.04% +0.000 pp | 0.00% 0.000 pp | USD2.12 -15.6% | 9 qtrs — |
| 57 | VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 64.9K +474.0 (+0.7%) | 116.2K -1.1K (-0.9%) | 0.04% +0.000 pp | 0.00% 0.000 pp | USD0.95 +88.4% | 4 qtrs — |
| 58 | ADAR1 CAPITAL MANAGEMENT, LLC | 50.6K +50.6K (+100.0%) | 90.6K +90.6K (+100.0%) | 0.03% +0.031 pp | 0.01% +0.007 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 59 | JEFFERIES FINANCIAL GROUP INC. | 44.3K -2.3K (-5.0%) | 79.2K -5.6K (-6.6%) | 0.03% -0.002 pp | 0.00% +0.000 pp | USD1.82 -1.6% | 2 qtrs — |
| 60 | CITIGROUP INC | 43.8K +37.9K (+635.2%) | 78.5K +67.6K (+623.1%) | 0.03% +0.023 pp | 0.00% +0.000 pp | USD3.23 -44.6% | 10 qtrs — |
| 61 | AMG NATIONAL TRUST BANK | 43.4K +— (+0.0%) | 77.6K -1.3K (-1.6%) | 0.03% +0.000 pp | 0.00% 0.000 pp | USD10.60 -83.1% | 5 qtrs — |
| 62 | BANK OF NEW YORK MELLON CORP | 39.2K +19.3K (+97.5%) | 70.1K +34.0K (+94.3%) | 0.02% +0.012 pp | 0.00% +0.000 pp | USD6.27 -71.5% | 9 qtrs — |
| 63 | AMERICAN CENTURY COMPANIES INC | 38.8K +38.8K (+100.0%) | 69.5K +69.5K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.000 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 64 | SIG BROKERAGE, LP | 33.1K -2.3K (-6.4%) | 59.3K -5.1K (-7.9%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD1.00 +79.0% | 4 qtrs — |
| 65 | VOLEON CAPITAL MANAGEMENT LP | 31.3K +31.3K (+100.0%) | 56.0K +56.0K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.001 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 66 | BARCLAYS PLC | 30.9K -98.3K (-76.1%) | 55.4K -1.7M (-96.8%) | 0.02% -0.061 pp | 0.00% 0.000 pp | USD2.87 -37.6% | 9 qtrs — |
| 67 | CATALYST FUNDS MANAGEMENT PTY LTD | 29.6K +— (+0.0%) | 53.0K -888.0 (-1.6%) | 0.02% +0.000 pp | 0.01% +0.004 pp | USD0.73 +145.2% | 3 qtrs — |
| 68 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 27.2K -1.2K (-4.1%) | 48.7K -2.9K (-5.7%) | 0.02% -0.001 pp | 0.00% -0.001 pp | USD10.58 -83.1% | 5 qtrs — |
| 69 | FRED ALGER MANAGEMENT, LLC | 22.2K +22.2K (+100.0%) | 39.7K +39.7K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 70 | WALLEYE CAPITAL LLC | 21.3K +21.3K (+100.0%) | 38.1K +38.1K (+100.0%) | 0.01% +0.013 pp | 0.00% +0.000 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 71 | HBK SORCE ADVISORY LLC | 17.0K +194.0 (+1.2%) | 36.1K +5.1K (+16.5%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD0.78 +129.5% | 3 qtrs — |
| 72 | LEGACY PRIVATE TRUST CO. | 19.0K +5.0K (+35.7%) | 34.0K +8.5K (+33.5%) | 0.01% +0.003 pp | 0.00% +0.001 pp | USD1.81 -1.1% | 9 qtrs — |
| 73 | TOWER RESEARCH CAPITAL LLC (TRC) | 17.7K -3.3K (-15.5%) | 31.7K -6.5K (-16.9%) | 0.01% -0.002 pp | 0.00% 0.000 pp | USD1.73 +3.5% | 9 qtrs — |
| 74 | CLARIUS GROUP, LLC | 17.0K +— (+0.0%) | 30.4K -509.0 (-1.6%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD13.21 -86.4% | 6 qtrs — |
| 75 | HSBC HOLDINGS PLC | 15.0K +15.0K (+100.0%) | 26.9K +26.9K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 76 | WOODLINE PARTNERS LP | 15.0K +— (+0.0%) | 26.8K -449.0 (-1.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD11.46 -84.4% | 7 qtrs — |
| 77 | IEQ CAPITAL, LLC | 13.2K -4.3K (-24.5%) | 23.6K -8.2K (-25.8%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD6.02 -70.3% | 8 qtrs — |
| 78 | BNP PARIBAS ARBITRAGE, SNC | 12.4K +9.7K (+361.4%) | 22.2K +17.3K (+353.8%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD1.85 -3.2% | 5 qtrs — |
| 79 | QUADRATURE CAPITAL LTD | 11.4K +11.4K (+100.0%) | 20.4K +20.4K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 80 | CREATIVE PLANNING | 10.9K +10.9K (+100.0%) | 19.5K +19.5K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 81 | JPMORGAN CHASE & CO | 10.5K -38.0 (-0.4%) | 18.8K -384.0 (-2.0%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD6.35 -71.8% | 9 qtrs — |
| 82 | WELLS FARGO & COMPANY/MN | 10.0K +5.0K (+100.0%) | 17.9K +8.8K (+96.7%) | 0.01% +0.003 pp | 0.00% +0.000 pp | USD7.49 -76.1% | 9 qtrs — |
| 83 | WALLEYE TRADING LLC | 8.6K +8.6K (+100.0%) | 15.4K +15.4K (+100.0%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 84 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 8.1K +1.9K (+29.7%) | 14.5K +3.1K (+27.5%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD7.52 -76.2% | 5 qtrs — |
| 85 | CWM, LLC | 5.2K -6.0K (-53.5%) | 9.0K -11.0K (-55.0%) | 0.00% -0.004 pp | 0.00% +0.000 pp | USD1.02 +75.5% | 7 qtrs — |
| 86 | GF FUND MANAGEMENT CO. LTD. | 3.3K -202.0 (-5.8%) | 5.9K -466.0 (-7.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD9.39 -80.9% | 5 qtrs — |
| 87 | ROYAL BANK OF CANADA | 2.9K +835.0 (+41.1%) | 5.0K +2.0K (+66.7%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD1.39 +28.8% | 10 qtrs — |
| 88 | RHUMBLINE ADVISERS | 2.6K +— (+0.0%) | 4.6K -78.0 (-1.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD11.09 -83.9% | 9 qtrs — |
| 89 | NISA INVESTMENT ADVISORS, LLC | 1.5K +— (+0.0%) | 2.6K -44.0 (-1.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.07 -70.5% | 8 qtrs — |
| 90 | PHYSICIAN WEALTH ADVISORS, INC. | 1.3K +— (+0.0%) | 2.4K -40.0 (-1.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.73 +145.2% | 3 qtrs — |
| 91 | FORTITUDE FAMILY OFFICE, LLC | 1.0K +— (+0.0%) | 1.8K -31.0 (-1.7%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD1.82 -1.6% | 2 qtrs — |
| 92 | PNC FINANCIAL SERVICES GROUP, INC. | 1.0K +— (+0.0%) | 1.8K -30.0 (-1.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.99 -74.4% | 5 qtrs — |
| 93 | OPTIVER HOLDING B.V. | 592.00 +592.0 (+100.0%) | 1.1K +1.1K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.79 +0.0% | 1 qtrs NEW |
| 94 | DAIWA SECURITIES GROUP INC. | 533.00 +— (+0.0%) | 1.0K +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.82 -1.6% | 5 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 49 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.04% | 578.6K | 0.60% |
| 2 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.02% | 99.1K | 0.40% |
| 3 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.02% | 225.0K | 0.20% |
| 4 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.02% | 16.0K | 0.19% |
| 5 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.02% | 221.8K | 0.35% |
| 6 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.02% | 14.8K | 0.35% |
| 7 | ProShares Ultra Nasdaq Biotechnology BIB | 0.01% | 10.4K | 1.19% |
| 8 | Invesco RAFI US 1500 Small-Mid ETF PRFZ | 0.01% | 297.6K | 0.34% |
| 9 | iShares Biotechnology ETF IBB | 0.01% | 930.4K | 0.44% |
| 10 | iShares Russell 2000 Growth ETF IWO | 0.01% | 1.47M | 0.24% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
5
Sells
0
Shares acquired
400.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+400,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | Piacquad David | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 1.86 | 148.8K | 80,000 | D | ↗ |
| 2026-05-27 | Ho Maykin | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 1.86 | 148.8K | 80,000 | D | ↗ |
| 2026-05-27 | Halawa Alaa | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 1.86 | 148.8K | 80,000 | D | ↗ |
| 2026-05-27 | Fust Matthew K | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 1.86 | 148.8K | 80,000 | D | ↗ |
| 2026-05-27 | Burow Kristina | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 80,000 | 1.86 | 148.8K | 80,000 | D | ↗ |
| 2026-02-17 | Pinto Joshua | Officer | S-Sale | D | Common Stock | 5,967 | 3.54 | 21.1K | 57,783 | D | ↗ |
| 2026-02-17 | Milligan Michael Lee | Officer | S-Sale | D | Common Stock | 1,436 | 3.57 | 5.1K | 21,034 | D | ↗ |
| 2026-02-17 | BERNS PAUL L | Director / Officer | S-Sale | D | Common Stock | 9,819 | 3.51 | 34.5K | 7,395,185 | D | ↗ |
| 2026-02-17 | Aurora Daljit Singh | Officer | S-Sale | D | Common Stock | 6,165 | 3.56 | 21.9K | 82,770 | D | ↗ |
| 2026-01-08 | Pinto Joshua | Officer | A-Award | A | Stock Option (Right to Buy) | 1,200,000 | 2.33 | 2.80M | 1,200,000 | D | ↗ |
| 2026-01-08 | Milligan Michael Lee | Officer | A-Award | A | Stock Option (Right to Buy) | 350,000 | 2.33 | 815.5K | 350,000 | D | ↗ |
| 2026-01-08 | Duncan Jason | Officer | A-Award | A | Stock Option (Right to Buy) | 750,000 | 2.33 | 1.75M | 750,000 | D | ↗ |
| 2026-01-08 | BERNS PAUL L | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 1,650,000 | 2.33 | 3.84M | 1,650,000 | D | ↗ |
| 2026-01-08 | Aurora Daljit Singh | Officer | A-Award | A | Stock Option (Right to Buy) | 750,000 | 2.33 | 1.75M | 750,000 | D | ↗ |
| 2025-11-11 | Aurora Daljit Singh | Officer | S-Sale | D | Common Stock | 114,703 | 2.68 | 307.0K | 0 | I | ↗ |
| 2025-10-27 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 1,915,700 | 2.61 | 5.00M | 6,046,907 | I | ↗ |
| 2025-10-27 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 1,915,700 | 2.61 | 5.00M | 6,046,907 | I | ↗ |
| 2025-10-27 | ARCH Venture Partners X, LLC | 10% Owner | P-Purchase | A | Common Stock | 1,915,700 | 2.61 | 5.00M | 6,046,907 | I | ↗ |
| 2025-05-28 | Pinto Joshua | Officer | A-Award | A | Stock Option (Right to Buy) | 223,034 | 0.72 | 160.6K | 223,034 | D | ↗ |
| 2025-05-28 | Piacquad David | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 0.72 | 57.6K | 80,000 | D | ↗ |
| 2025-05-28 | Milligan Michael Lee | Officer | A-Award | A | Stock Option (Right to Buy) | 400,000 | 0.72 | 288.0K | 400,000 | D | ↗ |
| 2025-05-28 | Ho Maykin | Director | A-Award | A | Stock Option (Right to Buy) | 28,571 | 0.72 | 20.6K | 28,571 | D | ↗ |
| 2025-05-28 | Halawa Alaa | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 0.72 | 57.6K | 80,000 | D | ↗ |
| 2025-05-28 | Fust Matthew K | Director | A-Award | A | Stock Option (Right to Buy) | 28,571 | 0.72 | 20.6K | 28,571 | D | ↗ |
| 2025-05-28 | Duncan Jason | Officer | A-Award | A | Stock Option (Right to Buy) | 500,000 | 0.72 | 360.0K | 500,000 | D | ↗ |
| 2025-05-28 | Burow Kristina | Director / 10% Owner | D-Return | D | Stock Option (Right to Buy) | 28,571 | 1.69 | 48.3K | 0 | D | ↗ |
| 2025-05-28 | BERNS PAUL L | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 2,000,000 | 0.72 | 1.44M | 2,000,000 | D | ↗ |
| 2025-05-28 | Aurora Daljit Singh | Officer | D-Return | D | Stock Option (Right to Buy) | 1,000,000 | 1.69 | 1.69M | 0 | D | ↗ |
| 2025-05-21 | Pinto Joshua | Officer | G-Gift | A | Common Stock | 13,202 | 0.00 | — | 152,167 | I | ↗ |
| 2025-02-18 | Pinto Joshua | Officer | S-Sale | D | Common Stock | 8,048 | 1.67 | 13.5K | 76,952 | D | ↗ |
| 2025-02-18 | Milligan Michael Lee | Officer | S-Sale | D | Common Stock | 1,978 | 1.69 | 3.4K | 22,470 | D | ↗ |
| 2025-02-18 | Lenz Robert A. | Officer | S-Sale | D | Common Stock | 5,614 | 1.67 | 9.4K | 309,092 | D | ↗ |
| 2025-02-18 | BERNS PAUL L | Director / Officer | S-Sale | D | Common Stock | 13,871 | 1.69 | 23.5K | 7,405,004 | D | ↗ |
| 2025-02-18 | Aurora Daljit Singh | Officer | S-Sale | D | Common Stock | 8,565 | 1.68 | 14.3K | 88,935 | D | ↗ |
| 2025-02-13 | Pinto Joshua | Officer | A-Award | A | Stock Option (Right to Buy) | 3,000,000 | 1.69 | 5.07M | 3,000,000 | D | ↗ |
| 2025-02-13 | Piacquad David | Director | A-Award | A | Stock Option (Right to Buy) | 46,455 | 1.69 | 78.5K | 46,455 | D | ↗ |
| 2025-02-13 | Milligan Michael Lee | Officer | A-Award | A | Stock Option (Right to Buy) | 38,234 | 1.69 | 64.6K | 38,234 | D | ↗ |
| 2025-02-13 | Lenz Robert A. | Officer | A-Award | A | Stock Option (Right to Buy) | 502,934 | 1.69 | 850.0K | 502,934 | D | ↗ |
| 2025-02-13 | Ho Maykin | Director | A-Award | A | Stock Option (Right to Buy) | 27,802 | 1.69 | 47.0K | 27,802 | D | ↗ |
| 2025-02-13 | Halawa Alaa | Director | D-Return | D | Stock Option (Right to Buy) | 28,571 | 9.95 | 284.3K | 0 | D | ↗ |
| 2025-02-13 | Fust Matthew K | Director | A-Award | A | Stock Option (Right to Buy) | 85,586 | 1.69 | 144.6K | 85,586 | D | ↗ |
| 2025-02-13 | Duncan Jason | Officer | A-Award | A | Stock Option (Right to Buy) | 500,000 | 1.69 | 845.0K | 500,000 | D | ↗ |
| 2025-02-13 | Burow Kristina | Director / 10% Owner | D-Return | D | Stock Option (Right to Buy) | 46,455 | 17.00 | 789.7K | 0 | D | ↗ |
| 2025-02-13 | BERNS PAUL L | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 2,000,000 | 1.69 | 3.38M | 2,000,000 | D | ↗ |
| 2025-02-13 | Aurora Daljit Singh | Officer | D-Return | D | Stock Option (Right to Buy) | 137,538 | 4.24 | 583.2K | 0 | I | ↗ |
| 2024-12-27 | BERNS PAUL L | Director | G-Gift | D | Common Stock | 133,097 | 0.00 | — | 7,685,069 | D | ↗ |
| 2024-10-18 | Fust Matthew K | Director | M-Exempt | A | Common Stock | 6,205 | 8.79 | 54.5K | 26,305 | D | ↗ |
| 2024-10-17 | Fust Matthew K | Director | M-Exempt | A | Common Stock | 2,156 | 2.52 | 5.4K | 27,839 | D | ↗ |
| 2024-10-10 | Lenz Robert A. | Officer | S-Sale | D | Common Stock | 8,260 | 15.09 | 124.6K | 314,706 | D | ↗ |
| 2024-10-09 | Lenz Robert A. | Officer | S-Sale | D | Common Stock | 5,563 | 15.01 | 83.5K | 322,966 | D | ↗ |
| 2024-09-18 | Lenz Robert A. | Officer | S-Sale | D | Common Stock | 10,676 | 12.09 | 129.1K | 328,529 | — | ↗ |
| 2024-09-17 | Lenz Robert A. | Officer | S-Sale | D | Common Stock | 30,788 | 11.81 | 363.7K | 339,205 | — | ↗ |
| 2024-09-12 | Lenz Robert A. | Officer | S-Sale | D | Common Stock | 32,948 | 11.43 | 376.7K | 369,993 | — | ↗ |
| 2024-09-12 | Aurora Daljit Singh | Officer | G-Gift | A | Stock Option (Right to Buy) | 136,210 | 6.51 | 886.7K | 136,210 | — | ↗ |
| 2023-12-11 | Duncan Jason | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-08 | Burow Kristina | Director / 10% Owner | J-Other | A | Common Stock | 1,176,593 | 0.00 | — | 4,131,207 | — | ↗ |
| 2023-12-08 | ARCH Venture Partners XII, LLC | 10% Owner | J-Other | A | Common Stock | 703,061 | 0.00 | — | 1,387,228 | — | ↗ |
| 2023-12-08 | ARCH Venture Partners X, LLC | 10% Owner | J-Other | A | Common Stock | 703,061 | 0.00 | — | 1,387,228 | — | ↗ |
| 2023-11-14 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 3,357 | 11.98 | 40.2K | 4,131,207 | — | ↗ |
| 2023-11-14 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 3,357 | 11.98 | 40.2K | 4,131,207 | — | ↗ |
| 2023-11-13 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 31,653 | 11.75 | 371.9K | 4,127,850 | — | ↗ |
| 2023-11-13 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 31,653 | 11.75 | 371.9K | 4,127,850 | — | ↗ |
| 2023-11-10 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 5,431 | 11.75 | 63.8K | 4,096,197 | — | ↗ |
| 2023-11-10 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 11,844 | 11.37 | 134.7K | 4,090,766 | — | ↗ |
| 2023-11-09 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 31,079 | 10.53 | 327.3K | 4,078,922 | — | ↗ |
| 2023-11-09 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 31,079 | 10.53 | 327.3K | 4,078,922 | — | ↗ |
| 2023-11-08 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 69,127 | 10.78 | 745.2K | 4,024,719 | — | ↗ |
| 2023-11-08 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 23,124 | 11.79 | 272.6K | 4,047,843 | — | ↗ |
| 2023-11-07 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 30,192 | 11.50 | 347.2K | 3,955,592 | — | ↗ |
| 2023-11-07 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 30,192 | 11.50 | 347.2K | 3,955,592 | — | ↗ |
| 2023-11-06 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 43,082 | 11.55 | 497.6K | 3,925,400 | — | ↗ |
| 2023-11-06 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 43,082 | 11.55 | 497.6K | 3,925,400 | — | ↗ |
| 2023-11-03 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 22,420 | 11.38 | 255.1K | 3,882,318 | — | ↗ |
| 2023-11-03 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 22,420 | 11.38 | 255.1K | 3,882,318 | — | ↗ |
| 2023-09-29 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 34,560 | 13.98 | 483.1K | 3,859,898 | — | ↗ |
| 2023-09-29 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 34,560 | 13.98 | 483.1K | 3,859,898 | — | ↗ |
| 2023-09-28 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 25,110 | 13.69 | 343.8K | 3,825,338 | — | ↗ |
| 2023-09-28 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 16,841 | 13.06 | 219.9K | 3,800,228 | — | ↗ |
| 2023-09-27 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 24,504 | 12.31 | 301.6K | 3,783,387 | — | ↗ |
| 2023-09-27 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 24,504 | 12.31 | 301.6K | 3,783,387 | — | ↗ |
| 2023-09-26 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 34,000 | 11.73 | 398.8K | 3,758,883 | — | ↗ |
| 2023-09-26 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 34,000 | 11.73 | 398.8K | 3,758,883 | — | ↗ |
| 2023-09-25 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 30,773 | 10.80 | 332.3K | 3,694,916 | — | ↗ |
| 2023-09-25 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 29,967 | 11.65 | 349.1K | 3,724,883 | — | ↗ |
| 2023-09-22 | Burow Kristina | Director / 10% Owner | P-Purchase | A | Common Stock | 40,000 | 11.14 | 445.6K | 3,664,143 | — | ↗ |
| 2023-09-22 | ARCH Venture Partners XII, LLC | 10% Owner | P-Purchase | A | Common Stock | 40,000 | 11.14 | 445.6K | 3,664,143 | — | ↗ |
| 2023-09-19 | Gosebruch Henry O | Director / Officer | P-Purchase | A | Common Stock | 15,000 | 12.62 | 189.4K | 15,000 | — | ↗ |
| 2023-09-19 | FMR LLC | Other | C-Conversion | A | Common Stock | 84,965 | 0.00 | — | 5,472,340 | — | ↗ |
| 2023-09-19 | Burow Kristina | Director / 10% Owner | C-Conversion | D | Series A-1 Preferred Stock | 1,144,973 | 0.00 | — | 0 | — | ↗ |
| 2023-09-19 | ARCH Venture Partners X, LLC | 10% Owner | C-Conversion | A | Common Stock | 1,144,973 | 0.00 | — | 1,144,973 | — | ↗ |
| 2023-09-14 | Piacquad David | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-14 | Ho Maykin | Director | — | D | Stock Option (Right to Buy) | 95,586 | 2.52 | 240.9K | 0 | — | ↗ |
| 2023-09-14 | Gosebruch Henry O | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 382,345 | — | ↗ |
| 2023-09-14 | Fust Matthew K | Director | — | D | Stock Option (Right to Buy) | 3,783 | 8.32 | 31.5K | 0 | — | ↗ |
| 2023-09-14 | FMR LLC | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,911,729 | — | ↗ |
| 2023-09-14 | Burow Kristina | Director / 10% Owner | — | I | Series A-2 Preferred Stock | 6,576,400 | 0.00 | — | 0 | — | ↗ |
| 2023-09-14 | BERNS PAUL L | Director | — | D | Stock Option (Right to Buy) | 497,049 | 4.63 | 2.30M | 0 | — | ↗ |
| 2023-09-14 | ARCH Venture Partners X, LLC | 10% Owner | — | I | Series A-2 Preferred Stock | 6,576,400 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
185.28M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Joshua Pinto, Ph.D. President | 645.0K | 989.4K | — | 4.64M | 464.4K | 1.1K | 6.74M | 68.86% | ↗ |
| 2 | 2025 | Paul L. Berns Chief Executive Officer | 700.0K | 21.0K | — | 3.33M | 504.0K | 11.3K | 4.56M | 72.90% | ↗ |
| 3 | 2025 | Bill Aurora, Pharm.D. Chief Strategy Officer | 545.0K | 870.2K | — | 1.55M | 323.6K | 9.3K | 3.30M | 47.06% | ↗ |
| 4 | 2025 | Henry O. Gosebruch Former President and Chief Executive Officer | 94.2K | 420.0K | — | 86.3K | — | 718.8K | 1.32M | 6.54% | ↗ |
| 5 | 2024 | Paul L. Berns Executive Chairman | 470.0K | — | 3.09M | 4.82M | 253.8K | 11.1K | 8.65M | 91.50% | ↗ |
| 6 | 2024 | Paul L. Berns Chief Executive Officer | 470.0K | — | 3.09M | 4.82M | 253.8K | 11.1K | 8.65M | 91.50% | ↗ |
| 7 | 2024 | Bill Aurora, Pharm.D. Chief Strategy Officer | 496.8K | — | 1.76M | 2.74M | 188.8K | 10.9K | 5.20M | 86.61% | ↗ |
| 8 | 2024 | Bill Aurora, Pharm.D. Chief Strategy Officer | 496.8K | — | 1.76M | 2.74M | 188.8K | 10.9K | 5.20M | 86.61% | ↗ |
| 9 | 2024 | Henry O. Gosebruch Former President and Chief Executive Officer | 700.0K | — | 1.45M | 2.25M | 378.0K | 11.1K | 4.79M | 77.24% | ↗ |
| 10 | 2024 | Henry O. Gosebruch President and Chief Executive Officer | 700.0K | — | 1.45M | 2.25M | 378.0K | 11.1K | 4.79M | 77.24% | ↗ |
| 11 | 2024 | Joshua Pinto, Ph.D. President | 508.7K | — | 1.54M | 2.39M | 193.3K | 780.00 | 4.63M | 84.82% | ↗ |
| 12 | 2023 | Henry O. Gosebruch President and Chief Executive Officer | 337.5K | 2.52M | 3.74M | 14.93M | 465.8K | 6.6K | 22.00M | 84.86% | ↗ |
| 13 | 2023 | Paul L. Berns Executive Chairman | 537.5K | 16.1K | — | 6.92M | 1.08M | 11.8K | 8.57M | 80.77% | ↗ |
| 14 | 2023 | Bill Aurora, Pharm.D. Chief Strategy Officer | 473.1K | — | — | 2.45M | 241.3K | 11.9K | 3.18M | 77.16% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joshua Pinto | President | 2M | male |
| Daljit Singh Aurora | Chief Operationg and development officer | 2M | — |
| Jason G. Duncan | Chief Legal & Administrative Officer | 315.0K | male |
| Lori Houle | Chief Technical Operations & Quality Officer | — | female |
| Michael Lee Milligan | Chief Financial Officer & Principal Accounting Officer | — | male |
| Nicholas Brandon | Chief Scientific Officer | — | male |
| Amy Sullivan | Chief Human Resources Officer | — | female |
| Pablo Gersberg | Chief Information Officer | — | male |
| Carol Suh | Co-Founder & Chief Strategy Officer | — | female |
| Helen Rubinstein | Head of Investor Relations | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NMRA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
